Franklin Genomic Advancements ETFHELX
HELX
$31.80
1.05%
Market Cap: $9.54M
0
Funds holding %
of 6,686 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
5.62% less ownership
Funds ownership: 31.67% [Q1] → 26.05% (-5.62%) [Q2]
20% less capital invested
Capital invested by funds: $3.11M [Q1] → $2.48M (-$636K) [Q2]
27% less funds holding
Funds holding: 11 [Q1] → 8 (-3) [Q2]
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Research analyst outlook
We haven’t received any recent analyst ratings for HELX.
Financial journalist opinion
We haven’t received any recent news articles for HELX.